Abciximab

Showing Results 1 - 11 of 11. RSS Feed
 Abciximab
Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.[1] While abciximab has a short plasma half-life, d...
reopro (abciximab) for cardiac ischemic complications
Post a Reply
ReoPro(Abciximab) is a monoclonal antibody that blocks the pathway to platelet aggregation and reduces cardiac ischemic complications in patients undergoing PCI (percutaneous coronary intervention). ...
Updated 9 years ago in ReoPro.
Fri, Oct 03 '08, 10:25 AM
 ReoPro Abciximab
Abciximab (previously known as c7E3 Fab), a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures like angioplasty to prevent platelets from sticking together and causing thrombus (blood clot) formation within the coronary artery. It is a glycoprotein IIb/IIIa inhibitor.[1] While abciximab has a short plasma half-life, d...
Monoclore
2 Replies RSS
Blood Thinner ## I am not sure if this helps but you might find information on ReoPro® (chemical name Abciximab) useful; This drug acts as a platelet aggregation inhibitor (blood thinning agent) during surgical procedures. ## Yes, ReoPro® is a monoclonal antibody directed against platelet receptors. Is Monoclore an actual trade or chemical name for another drug? If so, which country? ...
Updated 12 years ago in ReoPro.
Mon, Aug 22 '05, 12:50 PM
 Cromafiban
In medicine, glycoprotein IIb/IIIa inhibitors, also GpIIb/IIIa inhibitors, is a class of antiplatelet agents. Several GpIIb/IIIa inhibitors exist: abciximab (ReoPro) eptifibatide (Integrilin) tirofiban (Aggrastat) roxifiban orbofiban Use Glycoprotein IIb/IIIa inhibitors are frequently used during percutaneous coronary intervention (angioplasty with or without intracoronary stent placement). They work by preventing platelet aggregation and thrombus formation. They do so by inhibition of th...
 Normiflo Ardeparin
Ardeparin (trade name Normiflo) is an anticoagulant. It was used for the prevention of deep vein thrombosis, but was withdrawn from the US market in 2000.[1] References ^ Drugs.com: Normiflo v t e Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) Antiplatelet drugs Glycoprotein IIb/IIIa inhibitors Abciximab Eptifibatide Orbofiban Roxifiban Sibrafiban§ Tirofiban ADP receptor/P2Y12 inhibitors Thienopyridines Clopidogrel Prasugre...
 Ardeparin
Ardeparin (trade name Normiflo) is an anticoagulant. It was used for the prevention of deep vein thrombosis, but was withdrawn from the US market in 2000.[1] References ^ Drugs.com: Normiflo v t e Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) Antiplatelet drugs Glycoprotein IIb/IIIa inhibitors Abciximab Eptifibatide Orbofiban Roxifiban Sibrafiban§ Tirofiban ADP receptor/P2Y12 inhibitors Thienopyridines Clopidogrel Prasugre...
 Miradon Anisindione
Anisindione (brand name Miradon) is a synthetic anticoagulant and an indanedione derivative. It prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K–mediated gamma-carboxylation of precursor proteins. v t e Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) Antiplatelet drugs Glycoprotein IIb/IIIa inhibitors Abciximab Eptifibatide Orb...
 Anisindione
Anisindione (brand name Miradon) is a synthetic anticoagulant and an indanedione derivative. It prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K–mediated gamma-carboxylation of precursor proteins. v t e Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01) Antiplatelet drugs Glycoprotein IIb/IIIa inhibitors Abciximab Eptifibatide Orb...
 NDC 0002-7140
Reopro 2 mg/ml Intravenous Injection, Solution by Eli Lilly and Company ## Package Codes: 0002-7140-01 ## Active Ingredients: Abciximab
 NDC 57894-200
Reopro 2 mg/ml Intravenous Injection, Solution by Janssen Biotech, Inc. ## Package Codes: 57894-200-01 ## Active Ingredients: Abciximab


Can't Find What You're Looking For? Submit a New Topic Below

No registration is needed.
Simply fill out the form below.

 *
What are the main keywords of your topic?


 *
Please be detailed.

 *
You may use your first name, or for more privacy, make up a nickname.


 
Optional. Always hidden. This allows us to notify you when a reply is posted here.





5) Text Verification: *
Prevents SPAM.

Click here to show the question



This form will be submitted securely


TRUSTe

Discussion Thread Guidelines: Any participation in the discussion threads signifies your agreement with the Terms of Use. (1) Act civilized and be respectful towards others. No profanity, vulgarity or lewd / suggestive content is allowed. (2) Posts encouraging, facilitating, or seeking advice about the abuse of medications or other substances are prohibited. (3) Personal contact information (such as telephone numbers, email addresses, etc) is not allowed to appear on our discussion threads. (4) We do not allow our forums to be used for buying, selling, trading, or for the promotion of a product or service. (5) Posting external links to other web sites is not allowed without our prior approval. (6) We reserve the right to edit or remove content which we find objectionable to the community at our sole discretion.



Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 22 November 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.